Activation of diverse signalling pathways by oncogenic PIK3CA mutations

Xinyan Wu, Santosh Renuse, Nandini A. Sahasrabuddhe, Muhammad Saddiq Zahari, Raghothama Chaerkady, Min Sik Kim, Raja S. Nirujogi, Morassa Mohseni, Praveen Kumar, Rajesh Raju, Jun Zhong, Jian Yang, Johnathan Neiswinger, Jun Seop Jeong, Robert Newman, Maureen A. Powers, Babu Lal Somani, Edward Gabrielson, Saraswati Sukumar, Vered StearnsJiang Qian, Heng Zhu, Bert Vogelstein, Ben Ho Park, Akhilesh Pandey

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing driver oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets.

Original languageEnglish (US)
Article number4961
JournalNature communications
Volume5
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Cortactin
phosphorylation
mutations
Phosphatidylinositol 3-Kinases
Phosphotransferases
Chemical activation
Phosphorylation
activation
mutagenesis
Phosphopeptides
Protein Array Analysis
Mutation
phenotype
cultured cells
Mutagenesis
genes
quantitative analysis
Cell Movement
readout
cancer

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

Wu, X., Renuse, S., Sahasrabuddhe, N. A., Zahari, M. S., Chaerkady, R., Kim, M. S., ... Pandey, A. (2014). Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nature communications, 5, [4961]. https://doi.org/10.1038/ncomms5961

Activation of diverse signalling pathways by oncogenic PIK3CA mutations. / Wu, Xinyan; Renuse, Santosh; Sahasrabuddhe, Nandini A.; Zahari, Muhammad Saddiq; Chaerkady, Raghothama; Kim, Min Sik; Nirujogi, Raja S.; Mohseni, Morassa; Kumar, Praveen; Raju, Rajesh; Zhong, Jun; Yang, Jian; Neiswinger, Johnathan; Jeong, Jun Seop; Newman, Robert; Powers, Maureen A.; Somani, Babu Lal; Gabrielson, Edward; Sukumar, Saraswati; Stearns, Vered; Qian, Jiang; Zhu, Heng; Vogelstein, Bert; Park, Ben Ho; Pandey, Akhilesh.

In: Nature communications, Vol. 5, 4961, 01.01.2014.

Research output: Contribution to journalArticle

Wu, X, Renuse, S, Sahasrabuddhe, NA, Zahari, MS, Chaerkady, R, Kim, MS, Nirujogi, RS, Mohseni, M, Kumar, P, Raju, R, Zhong, J, Yang, J, Neiswinger, J, Jeong, JS, Newman, R, Powers, MA, Somani, BL, Gabrielson, E, Sukumar, S, Stearns, V, Qian, J, Zhu, H, Vogelstein, B, Park, BH & Pandey, A 2014, 'Activation of diverse signalling pathways by oncogenic PIK3CA mutations', Nature communications, vol. 5, 4961. https://doi.org/10.1038/ncomms5961
Wu X, Renuse S, Sahasrabuddhe NA, Zahari MS, Chaerkady R, Kim MS et al. Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nature communications. 2014 Jan 1;5. 4961. https://doi.org/10.1038/ncomms5961
Wu, Xinyan ; Renuse, Santosh ; Sahasrabuddhe, Nandini A. ; Zahari, Muhammad Saddiq ; Chaerkady, Raghothama ; Kim, Min Sik ; Nirujogi, Raja S. ; Mohseni, Morassa ; Kumar, Praveen ; Raju, Rajesh ; Zhong, Jun ; Yang, Jian ; Neiswinger, Johnathan ; Jeong, Jun Seop ; Newman, Robert ; Powers, Maureen A. ; Somani, Babu Lal ; Gabrielson, Edward ; Sukumar, Saraswati ; Stearns, Vered ; Qian, Jiang ; Zhu, Heng ; Vogelstein, Bert ; Park, Ben Ho ; Pandey, Akhilesh. / Activation of diverse signalling pathways by oncogenic PIK3CA mutations. In: Nature communications. 2014 ; Vol. 5.
@article{a04348a9d57645b28a75d084327ebd40,
title = "Activation of diverse signalling pathways by oncogenic PIK3CA mutations",
abstract = "The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing driver oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets.",
author = "Xinyan Wu and Santosh Renuse and Sahasrabuddhe, {Nandini A.} and Zahari, {Muhammad Saddiq} and Raghothama Chaerkady and Kim, {Min Sik} and Nirujogi, {Raja S.} and Morassa Mohseni and Praveen Kumar and Rajesh Raju and Jun Zhong and Jian Yang and Johnathan Neiswinger and Jeong, {Jun Seop} and Robert Newman and Powers, {Maureen A.} and Somani, {Babu Lal} and Edward Gabrielson and Saraswati Sukumar and Vered Stearns and Jiang Qian and Heng Zhu and Bert Vogelstein and Park, {Ben Ho} and Akhilesh Pandey",
year = "2014",
month = "1",
day = "1",
doi = "10.1038/ncomms5961",
language = "English (US)",
volume = "5",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Activation of diverse signalling pathways by oncogenic PIK3CA mutations

AU - Wu, Xinyan

AU - Renuse, Santosh

AU - Sahasrabuddhe, Nandini A.

AU - Zahari, Muhammad Saddiq

AU - Chaerkady, Raghothama

AU - Kim, Min Sik

AU - Nirujogi, Raja S.

AU - Mohseni, Morassa

AU - Kumar, Praveen

AU - Raju, Rajesh

AU - Zhong, Jun

AU - Yang, Jian

AU - Neiswinger, Johnathan

AU - Jeong, Jun Seop

AU - Newman, Robert

AU - Powers, Maureen A.

AU - Somani, Babu Lal

AU - Gabrielson, Edward

AU - Sukumar, Saraswati

AU - Stearns, Vered

AU - Qian, Jiang

AU - Zhu, Heng

AU - Vogelstein, Bert

AU - Park, Ben Ho

AU - Pandey, Akhilesh

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing driver oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets.

AB - The PIK3CA gene is frequently mutated in human cancers. Here we carry out a SILAC-based quantitative phosphoproteomic analysis using isogenic knockin cell lines containing driver oncogenic mutations of PIK3CA to dissect the signalling mechanisms responsible for oncogenic phenotypes induced by mutant PIK3CA. From 8,075 unique phosphopeptides identified, we observe that aberrant activation of PI3K pathway leads to increased phosphorylation of a surprisingly wide variety of kinases and downstream signalling networks. Here, by integrating phosphoproteomic data with human protein microarray-based AKT1 kinase assays, we discover and validate six novel AKT1 substrates, including cortactin. Through mutagenesis studies, we demonstrate that phosphorylation of cortactin by AKT1 is important for mutant PI3K-enhanced cell migration and invasion. Our study describes a quantitative and global approach for identifying mutation-specific signalling events and for discovering novel signalling molecules as readouts of pathway activation or potential therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=84921569189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921569189&partnerID=8YFLogxK

U2 - 10.1038/ncomms5961

DO - 10.1038/ncomms5961

M3 - Article

C2 - 25247763

AN - SCOPUS:84921569189

VL - 5

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 4961

ER -